Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From BostonGene Corp.
During Q2, biopharmas brought in an aggregate $12.5bn in financing and device company fundraising totaled $3.7bn; while in vitro diagnostic firms and research tools players raised $720m.
The firms hope academic research can yield first-in-class therapies and spinout companies. Also, Yale unveils research alliances with three biotechs.
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Artificial Intelligence